PhaseBio Pharmaceuticals (NASDAQ:PHAS – Get Free Report) and ImmunoPrecise Antibodies (NASDAQ:IPA – Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, analyst recommendations, earnings, risk, valuation, profitability and institutional ownership. Insider & Institutional Ownership 49.0% of PhaseBio […]